To assess the effects of sodium nitroprusside (5-10 gg/min) on total and regional cardiac performance, energetics, and lactate metabolism during acute ischemia, studies were performed in 21 open-chest dogs. For studies of regional function and metabolism, length gauges were sutured to the epicardial surface and an epicardial vein adjacent to the artery to be occluded was cannulated.
myocardial oxygen supply that exceeds the reduction in oxygen demand.6-8 Furthermore, the effects of nitroprusside on the mechanical function of the regional ischemic myocardium are unknown. This lack of information is primarily due to the difficulty of obtaining simultaneous measurements of regional function and metabolism of the heart in man. Accordingly, in this study an experimental model was used in which, in addition to evaluation of total cardiac function, the systolic shortening, venous blood flow, oxygen extraction, and lactate balance of the regional ischemic myocardium could be studied during the administration of the vasodilator sodium nitroprusside.
Methods
Studies were carried out in 21 healthy mongrel dogs weighing from 22 to 28 kg. The animals received 2.2 mg/kg of morphine sulfate, intramuscularly, 20 minutes prior to anesthesia with chloralose (100 mg/kg, intravenously). After endotracheal intubation, respiration was maintained with a Harvard ventilator. A left thoracotomy was performed via the fifth interspace, and the heart was suspended in a pericardial cradle. The distal portion of the left anterior descending coronary artery (LAD) or one of its diagonal branches was isolated for subsequent occlusion. The sinus node was externally crushed and the heart rate maintained constant by atrial pacing, at an average of 110 beats/min. Systemic arterial pressure was continuously monitored with Circulation, Volume 52, September 1975 a P23Db pressure transducer (Statham Instruments, Hato Rey, Puerto Rico) by a transfemoral catheter advanced to the thoracic aorta. Left ventricular pressure was recorded by a transducer (Model BT-70, Bio-Tech, Pasadena, California), connected to a 1OF catheter inserted in the ventricle through the apex. Left ventricular end-diastolic pressure (LVEDP) was controlled by the use of a large atrial catheter connected to a variable height reservoir. Fresh blood from a donor dog was used for infusion.
Cardiac output (CO) was determined by an ascending aortic electromagnetic flowmeter (Model RC1000, Micron Instruments, Los Angeles, California). Total peripheral resistance (TPR) and left ventricular stroke work (SW) were calculated by the formulae: TPR = AP/CO SW = SV x (AP -LVEDP) X 0.0136 where SV = stroke volume and AP = mean arterial pressure.
For assessment of the regional function, a 1 cm mercuryin-silastic length gauge (0.31 mm, inner diameter; 0.62 mm, outer diameter) (Parks Electronics, Beaverton, Oregon) was sutured to the epicardial surface of the left ventricle parallel to the fibers perfused by the coronary artery to be occluded.9 Previously the stiffness of the gauge had been determined and found to be 1 gr force/5% elongation. 
Protocol
The experimental protocol was designed to allow study of the effects of altered afterload alone, and then the effects of simultaneous alteration in preload and afterload. To achieve this end, the following procedure was followed:
1) The LVEDP was raised to approximately 12 3) In the remaining 30 minutes of nitroprusside administration, the LVEDP was allowed to fall to levels of 6-7 mm Hg. The administration of sodium nitroprusside was titrated in order to produce a significant reduction in peripheral resistance while the mean arterial pressure was maintained within a physiological range; the dose varied from 5 to 10 ,ug/min. In seven control animals the same procedure was followed but nitroprusside was not administered. The animals were observed for a total of 80 minutes following LAD occlusion.
Statistical Analysis
The paired Student's t-test was used for statistical analysis. Results are presented as mean + standard error of the mean.
Results

Cardiac Function and Systemic Hemodynamics
Following coronary occlusion, reduction in mean arterial pressure, cardiac output, stroke volume, and stroke work were observed in both the control animals and in the dogs which subsequently received nitroprusside (table 1). In the control dogs these changes persisted throughout the experiment. However, in the group of animals that received nitroprusside following LAD occlusion, cardiac output and stroke volume increased significantly, while the peripheral resistance was significantly reduced ( fig. 1 ).
The effects of sodium nitroprusside on systemic blood flow and blood pressure were related to the level of LVEDP. When the LVEDP was maintained at approximately 12 mm Hg, the cardiac output increased by a mean of 44%, and no significant changes were observed in mean arterial pressure. As the LVEDP was allowed to drop to levels of 6-7 mm Hg, the cardiac output was reduced to 1 mm 80 minutes after LAD occlusion. To the contrary, among the nitroprusside-treated animals ( fig. 2) , systolic shortening increased from 1.10 ± 0.24 to 1.77 ± 0.30 mm (P < 0.005). In figure 3 a typical experiment is shown This increase in regional contraction was observed even when preload was allowed to decrease in the second phase of nitroprusside administration.
Blood Flow and Metabolism of the Regional Ischemic Myocardium
Venous blood flow from the ischemic zone was measured in 12 dogs. In the control state, venous flow was approximately 4.0 ml/min. Following LAD occlusion a sharp drop in this local outflow was observed in all the animals. In the four control dogs the regional flow remained decreased and averaged 2.4 ± 0.05 ml/min at the end of the experiment. Among the dogs that received nitroprusside, the regional flow increased from 1.9 ± 0.1 ml/min to 3.0 ± 0.4 ml/min (P < 0.05) during the drug administration, even though the mean aortic pressure was significantly lower than the postocclusion values ( fig. 4) .
Reduction in regional flow following LAD occlusion was associated with significant reduction in local pH, no statistically significant change in P02, and a small but statistically significant increase in arteriovenous oxygen difference and oxygen extraction ratio (table  2) . Following nitroprusside, arterial P02 was essentially unchanged, while coronary sinus and regional venous P02 increased; concomitantly, arteriovenous oxygen difference and oxygen extraction ratio decreased significantly in both the total heart and regional ischemic myocardium. Nitroprusside did not induce significant changes in the regional venous pH.
Circulation, Volume 52, September 1975 Changes in myocardial lactate metabolism paralleled those in perfusion. In the preocclusion period the lactate balance was within normal limits in all the animals, averaging 35 and 33% in the control and treated groups, respectively. Following coronary artery occlusion, regional lactate extraction shifted to production. In contrast, only a decrease in the lactate extraction was demonstrated in the coronary sinus blood. In the control group ( fig. 5a ) regional lactate balance remained negative throughout the experiment, becoming slightly more negative toward the end of the period of observation. In treated group, however, the mean negative lactate balance decreased from -61% to -23% and this change was statistically significant ( fig. 5b ).
Discussion
In this study infusion of sodium nitroprusside increased cardiac output substantially and decreased arterial pressure slightly as total peripheral resistance was reduced. Since heart rate was held constant, the increase in cardiac output was due solely to an augmentation in stroke volume. Papillary muscle studies1 have indicated that sodium nitroprusside does not have a positive inotropic effect; therefore, enhancement of myocardial contractility is unlikely to explain the increase in stroke volume. Preload also was maintained constant, although at different levels in the two phases of the experiment. Therefore, the reduction in resistance to left ventricular ejection remains as the most likely cause for the increase in stroke volume and cardiac output.
Ross and Braunwald12 demonstrated that increasing afterload by angiotensin infusion produced a further reduction in cardiac performance in clinical heart failure. Our results are consistent with this study and may be interpreted as its counterpart since it shows an increase in cardiac performance when the afterload is decreased. Our results are also consistent with previous studies in man by Chatterjee et al. 1 Improvement in the function of the ischemic myocardial segment was associated with a decrease in both lactate production and arteriovenous oxygen difference, suggesting that the improved effective mechanical performance was not accompanied by an aggravation of the imbalance between oxygen supply and demand. This is in contrast to the effect of isoproterenol, which increases transiently the contractility of the ischemic segment, but also increases the magnitude of myocardial ischemia.fi 16 Since nitroprusside administration reduced both afterload and preload in the second phase of these experiments, the trend toward diminished regional lactate production might be explained solely on the basis of a decrease in myocardial oxygen demand. In addition, however, nitroprusside administration resulted in a consistent increase in the venous outflow from the ischemic area despite the fact that coronary perfusion pressure had been decreased. These data strongly suggest that collateral blood flow to the ischemic area was increased. The hypothesis is consistent with the known effects of an analogous group of vasodilator drugs, including nitroglycerin19 20 and with the recent demonstration that total coronary blood flow in dogs increased by 53% during nitroprusside infusion.2' This increase in local flow in the presence of a reduction in perfusion pressure presumably reflects a direct vasodilatory effect upon regional collateral vessels, since hypotension induced by hemorrhage led to a reduction in regional coronary perfusion.ff 7 The significant reductions in regional arteriovenous oxygen difference and oxygen extraction ratio after nitroprusside infusion were somewhat unexpected. Complete relief of the imbalance between oxygen supply and demand might be expected to result in narrowing of the regional arteriovenous oxygen difference; however, the response of both regional function and lactate metabolism indicates that improvement was not complete. Therefore, it should be noted that apparent reduction in both oxygen extraction and lactate production could be due in part to a pharmacologically induced arteriovenous shunt. In addition, the decrease in lactate production could be partially due to a dilutional effect accounted for by the increment in regional venous flow without a true reduction in lactate output from the ischemic zone. In such circumstances, however, regional function could be expected to deteriorate, and this was not the case.
Within the constraints of the experimental model, therefore, this study indicates that nitroprusside administration produced improved total cardiac performance in the presence of acute myocardial ischemia. Contributory to the improvement in over-all cardiac function is the increase in systolic contraction of the ischemic segment. Moreover, improved performance of the ischemic myocardium does not occur at the cost of aggravation in ischemia. Improved regional myocardial lactate balance, in turn, is apparently a result of both an increase in myocardial oxygen supply and a reduction in oxygen demand. Since this experimental model resembles the clinical condition in which nitroprusside is administered, these results tend to support the use of sodium nitroprusside in selected groups of patients with left ventricular failure following acute myocardial infarction.
